LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 6.94 | 771.67 | 987 | 1045 | 0.9444 | 0.7549 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 9.16 | 771.67 | 1102 | 1138 | 0.9679 | 0.8872 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 9.16 | 771.67 | 1090 | 1138 | 0.9574 | 0.8507 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 11.56 | 771.67 | 1180 | 1280 | 0.9214 | 0.7881 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 11.56 | 771.67 | 1222 | 1280 | 0.9542 | 0.8758 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 13.78 | 771.67 | 1344 | 1459 | 0.9207 | 0.8282 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 13.78 | 771.67 | 1388 | 1459 | 0.9509 | 0.8933 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 16.00 | 771.67 | 1499 | 1585 | 0.9454 | 0.8949 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 16.00 | 771.67 | 1497 | 1585 | 0.9442 | 0.8924 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.22 | 771.67 | 1595 | 1741 | 0.9159 | 0.8559 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 18.22 | 771.67 | 1655 | 1741 | 0.9504 | 0.9152 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 20.44 | 771.67 | 1704 | 1910 | 0.8917 | 0.8323 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 20.44 | 771.67 | 1766 | 1910 | 0.9242 | 0.8830 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 22.66 | 771.67 | 1858 | 2141 | 0.8676 | 0.8161 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 22.66 | 771.67 | 1923 | 2141 | 0.8980 | 0.8591 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.89 | 771.67 | 2059 | 2397 | 0.8587 | 0.8222 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 24.89 | 771.67 | 2132 | 2397 | 0.8892 | 0.8614 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.11 | 771.67 | 2338 | 2675 | 0.8740 | 0.8553 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.11 | 771.67 | 2420 | 2675 | 0.9046 | 0.8913 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 29.33 | 771.67 | 2603 | 2939 | 0.8856 | 0.8779 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 29.33 | 771.67 | 2708 | 2939 | 0.9213 | 0.9168 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 31.55 | 771.67 | 2818 | 3196 | 0.8815 | 0.8807 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 31.55 | 771.67 | 3068 | 3196 | 0.9597 | 0.9603 | MN20160304_L01 | F13 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 33.78 | 771.67 | 3008 | 3499 | 0.8595 | 0.8659 | MN20160304_L01 | F04 |
MCF 10A-H2B-mCherry | Neratinib | 0.01 | 33.78 | 771.67 | 3351 | 3499 | 0.9575 | 0.9606 | MN20160304_L01 | F13 |